Preview

Global Insulin Market Outlook 2018

Satisfactory Essays
Open Document
Open Document
276 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Global Insulin Market Outlook 2018
About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has remained as a standard treatment for both Type I diabetes. The report covers insulin market break up by mode of action and synthesis. Our extensive study looks into the competitive landscape key players in the insulin market covering business overview, product portfolio, market share and company level activities.Owing to the growing prevalence of diabetes and progressive nature of the disease, the global insulin market is forecasted to grow at a CAGR of over 10% during 2012-2018.

And More Visit:- http://www.rncos.com/Market-Analysis-Reports/Global-Insulin-Market-Outlook-2018-IM681.htm Our RNCOS research report, “Global Insulin Market Outlook 2018”, has revealed that the Insulin market has witnessed huge growth prospects based on these novel insulin delivery device systems. Recent advancements in administration of insulin include inhalable insulin, topical patches, spray insulin and painless insulin pens/pumps. Our comprehensive research work also studies how patent expiry of block buster insulin products would create opportunities for biosimilars. The report conducts an in-depth analysis of diabetic patient population across leading geographies including India, China, US, Russia, etc. to understand the structure of the insulin market in these countries. The report covers insulin market break up by mode of action and synthesis. Our extensive study looks into the competitive landscape key players in the insulin market covering business overview, product portfolio, market share and company level activities. Overall, the research aims at presenting a balanced picture of the global insulin market to the clients.

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the T2D therapeutics market.…

    • 1008 Words
    • 8 Pages
    Satisfactory Essays
  • Best Essays

    Ldr 531 Week 5

    • 2421 Words
    • 10 Pages

    Plunkett, J. W. (August 19, 2010). Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2009. [Electronic version]. Biotechnology, Drugs & Genetics Industry. Retrieved October 24, 2010 from http://www.plunkettresearchonline.com…

    • 2421 Words
    • 10 Pages
    Best Essays
  • Good Essays

    The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale, product differentiation, government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct competition with one another,…

    • 1056 Words
    • 5 Pages
    Good Essays
  • Good Essays

    According In 2012, 29.1 million people in the United States, approximately 9.3% of the population were diagnosed with diabetes mellitus, of whom 90% to 95% of adults had type 2 diabetes[1]. Although drug costs are increasing, the greatest component of the economic burden of T2DM is the treatment of diabetic complications, which can be reduced with effective management of the disease[2]. The SGLT2 inhibitors are a novel anti-diabetic agents with similar glycemic efficacy to other oral anti-hyperglycemic agents and low risk for hypoglycemia. There is a lack of published literature evaluating the economic benefits of SGLT2 inhibitors such as dapagliflozin. This cost-effectiveness analysis evaluates the long-term economic consequences of SGLT2…

    • 305 Words
    • 2 Pages
    Good Essays
  • Better Essays

    Your Name: Javeria Awan My Name: Professor Preston Cameron Class Number & Name: SBU200 27702, Business and Society Date: October 27, 2014 Case Analysis – Case # and Case Title: Big Pharma’s Marketing Tactics Contents Introduction: 1 Issues faced by Big Pharma: 1 My Analysis: 2 The stake holders: 2 Consumers: 2 Community: 2 Government: 2 Doctors and Medical Students: 2 My perspective: 2…

    • 1080 Words
    • 5 Pages
    Better Essays
  • Good Essays

    In 2012 diabetes cost NHS in the UK approximately 14 billion pounds for treating it and its complications (Kanavos et al. 2012). A report by Health and Social Care Information Centre (2014) reported that more than 45 million medications prescribed to treat diabetes in the England during 2013-14, the estimated cost of these medications was around 800 million pounds. However, a study by Khan (2015) empathizes that the consumption of artificial sweeteners can assist patients who suffer from diabetes to control the glucose level in their blood. Therefore, the consumption of these sweeteners has a positive effect on the economy by reducing the health care for diabetic…

    • 950 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    The pharmaceutical market in general is consisting of many stockholders and it consist of many layers…

    • 2327 Words
    • 10 Pages
    Powerful Essays
  • Powerful Essays

    Biosimilars are predicted to face low uptake due to the lack of regulatory guidelines in some markets, such as the US…

    • 774 Words
    • 4 Pages
    Powerful Essays
  • Satisfactory Essays

    Biopure Case

    • 196 Words
    • 1 Page

    In regard to this topic, among all of the case studies assigned by Dr. Mena, the case about Biopure Corp stood out as a significant example of overestimating some aspects of the strategic planning that led to the failure of the business. Biopure Corp had spent million of dollars on research and development to create two versions of blood substitute for human and animal called Hemopure and Oxyglobin. During the strategic planning process, Biopure was optimistic with both Hemopure and Oxyglobin because of Oxyglobin high acceptance rate among the consumers for a market research survey and it was already approved for release by the FDA. However, the company made a fatal mistake of underestimating the government regulation and strategic uncertainty…

    • 196 Words
    • 1 Page
    Satisfactory Essays
  • Good Essays

    Drug manufacturers need to regain access to these markets to protect themselves in a dynamic industry. In just a few years, from the early to the mid-1990s, the healthcare industry witnessed dramatic changes within its supply chain. Even if a merger did not bring about short term profits, like Eli Lilly and PCS, it still eliminates a deadly threat. Merck’s competitors were gaining ground by being placed on Medco formularies (Pg.16). If one of these companies were to get complete control, it could replace most of Merck’s products with its own. In a way, this acquisition was an investment to properly position Merck in an unpredictable future. If this future held a system in which the most drugs were sold through PBMs, or not, Merck would be positioned to continue their successful business. As one Merck-Medco put it “Our business is constantly changing.” (Pg. 19). This merger had to occur to create a company flexible and agile enough to adapt to a changes.…

    • 692 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    A topic of interest in the medical field for any disease is always finding a cure. But what if one has already been found? Moreover, what if it’s being hidden by pharmacies and drug companies to protect the large profits these companies make off of patients? Many conspiracists believe that this is occurring today, specifically with diabetes. Though pharma companies do have a large impact on drug and cure research, there is simply not enough evidence that a cure has been found. My goal in this essay is to support the claim that the market is in fact not sitting on a cure for a disease, that according to the CDC, nearly 26 million people are diagnosed with in the United States today.…

    • 1512 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    There are lot of pros for Diabeteck patenting their transdermal insulin delivery system. First of all, is the advantage competitive that the company gets in comparison with their competitors, usually the market recognizes companies that patenting exceptional ideas and new methods. Besides that, it’s an opportunity to Diabeteck to improve their brand and create a stronger company. According to Backoffice Pro, patents foster invention and innovation, as well as encouraging inventors to fully explain what’s being invented and how it works ( 2016,para 2). And finally, patenting their invention will protect them against other company working on the same system.…

    • 355 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    sugammadox

    • 327 Words
    • 1 Page

    Today’s finance is challenging in the medical environment. Cost seems to be of central concern to decision makers. This could lead you to wonder if research and development can flourish. To develop a new medication is costly and the payoff might appear in jeopardy to those that invest. Recently a new ground breaking drug called Sugammadex has been approved for use in over 40 countries around the world but further delayed in the U.S.…

    • 327 Words
    • 1 Page
    Good Essays
  • Best Essays

    Marino, J. (2009). Big Pharma’s Mid-Market Influence. Mergers & Acquisitions Report, 22(18), 12. Retrieved from EBSCOhost.…

    • 1899 Words
    • 8 Pages
    Best Essays
  • Good Essays

    * Pfizer: Pharmaceutical companies have low pressures for local responsiveness as their products serve universalistic needs. Cost pressures on the other hand are intense therefore the most appropriate strategy is a Global one.…

    • 670 Words
    • 3 Pages
    Good Essays